SG11202002327PA - Methods and systems for performing a patient-specific immunotherapy procedure with chain-of-custody and chain-of-identity biological sample tracking - Google Patents
Methods and systems for performing a patient-specific immunotherapy procedure with chain-of-custody and chain-of-identity biological sample trackingInfo
- Publication number
- SG11202002327PA SG11202002327PA SG11202002327PA SG11202002327PA SG11202002327PA SG 11202002327P A SG11202002327P A SG 11202002327PA SG 11202002327P A SG11202002327P A SG 11202002327PA SG 11202002327P A SG11202002327P A SG 11202002327PA SG 11202002327P A SG11202002327P A SG 11202002327PA
- Authority
- SG
- Singapore
- Prior art keywords
- chain
- custody
- patient
- systems
- methods
- Prior art date
Links
- 238000000034 method Methods 0.000 title 2
- 239000012472 biological sample Substances 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A61K39/4611—
-
- A61K39/4631—
-
- A61K39/4632—
-
- A61K39/464499—
-
- A61K39/464838—
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/08—Logistics, e.g. warehousing, loading or distribution; Inventory or stock management
- G06Q10/083—Shipping
- G06Q10/0833—Tracking
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Primary Health Care (AREA)
- Medical Informatics (AREA)
- Business, Economics & Management (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Economics (AREA)
- General Business, Economics & Management (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Operations Research (AREA)
- Tourism & Hospitality (AREA)
- Human Resources & Organizations (AREA)
- General Physics & Mathematics (AREA)
- Marketing (AREA)
- Development Economics (AREA)
- Quality & Reliability (AREA)
- Strategic Management (AREA)
- Theoretical Computer Science (AREA)
- Entrepreneurship & Innovation (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762559330P | 2017-09-15 | 2017-09-15 | |
| US201762566912P | 2017-10-02 | 2017-10-02 | |
| PCT/US2018/051298 WO2019055896A1 (en) | 2017-09-15 | 2018-09-17 | METHODS AND SYSTEMS FOR PERFORMING A PATIENT-CLEAN IMMUNOTHERAPY PROCEDURE WITH FOLLOW-UP OF BIOLOGICAL SAMPLE CHAIN OF CONTROL AND IDENTITY CHAIN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202002327PA true SG11202002327PA (en) | 2020-04-29 |
Family
ID=63878791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202002327PA SG11202002327PA (en) | 2017-09-15 | 2018-09-17 | Methods and systems for performing a patient-specific immunotherapy procedure with chain-of-custody and chain-of-identity biological sample tracking |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20200268860A1 (ja) |
| EP (2) | EP4035674A1 (ja) |
| JP (3) | JP2020537635A (ja) |
| KR (2) | KR20230052312A (ja) |
| CN (2) | CN111315403A (ja) |
| AU (2) | AU2018334279A1 (ja) |
| CA (1) | CA3075619A1 (ja) |
| IL (1) | IL273234A (ja) |
| SG (1) | SG11202002327PA (ja) |
| WO (1) | WO2019055896A1 (ja) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| EP3092049A1 (en) | 2014-01-08 | 2016-11-16 | Flodesign Sonics Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| CN111315403A (zh) * | 2017-09-15 | 2020-06-19 | 凯德药业股份有限公司 | 用于进行具有监管链和身份链生物样品跟踪的患者特异性免疫疗法规程的方法和系统 |
| CA3085784A1 (en) | 2017-12-14 | 2019-06-20 | Flodesign Sonics, Inc. | Acoustic transducer driver and controller |
| CA3118511C (en) | 2018-11-29 | 2024-04-30 | Vineti Inc. | Centralized and decentralized individualized medicine platform |
| US11321652B1 (en) | 2019-02-20 | 2022-05-03 | Vineti Inc. | Smart label devices, systems, and methods |
| IL297442A (en) * | 2020-04-22 | 2022-12-01 | Iovance Biotherapeutics Inc | Systems and methods for coordinating production of cells for patient-specific immunotherapy |
| KR20230137340A (ko) | 2020-12-30 | 2023-10-04 | 알로노스 테라퓨틱스 인코포레이티드 | 폴리시스트로닉 발현 카세트를 포함하는 재조합 벡터및 이의 사용 방법 |
| WO2022210581A1 (ja) * | 2021-03-31 | 2022-10-06 | 昭和電工マテリアルズ株式会社 | 情報管理装置及びコンピュータプログラム |
| EP4323943A1 (en) * | 2021-04-16 | 2024-02-21 | Kite Pharma, Inc. | Methods and systems for scheduling a patient-specific immunotherapy procedure |
| US11615874B1 (en) | 2021-09-30 | 2023-03-28 | Vineti Inc. | Personalized medicine and therapies platform |
| EP4423755A2 (en) * | 2021-10-27 | 2024-09-04 | Iovance Biotherapeutics, Inc. | Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy |
| WO2024107646A1 (en) * | 2022-11-14 | 2024-05-23 | Caribou Biosciences, Inc. | Anti-cll-1 chimeric antigen receptors, engineered cells and related methods |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5728388A (en) | 1989-10-03 | 1998-03-17 | Terman; David S. | Method of cancer treatment |
| US6319494B1 (en) | 1990-12-14 | 2001-11-20 | Cell Genesys, Inc. | Chimeric chains for receptor-associated signal transduction pathways |
| IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| US6406699B1 (en) | 1999-10-05 | 2002-06-18 | Gary W. Wood | Composition and method of cancer antigen immunotherapy |
| US6969519B2 (en) * | 2000-03-10 | 2005-11-29 | Human Genome Sciences, Inc. | Methods of using an agonistic antibody human tumor necrosis factor receptor (TR17) |
| AU2002368077B2 (en) | 2001-07-12 | 2010-03-04 | Jefferson Foote | Super humanized antibodies |
| US20040014194A1 (en) | 2002-03-27 | 2004-01-22 | Schering Corporation | Beta-secretase crystals and methods for preparing and using the same |
| GB0700058D0 (en) | 2007-01-03 | 2007-02-07 | Scancell Aps | Anti-tumor vaccine based on normal cells |
| PL3214091T3 (pl) | 2010-12-09 | 2019-03-29 | The Trustees Of The University Of Pennsylvania | Zastosowanie komórek T modyfikowanych chimerycznymi receptorami antygenowymi do leczenia nowotworów |
| US9402865B2 (en) * | 2011-01-18 | 2016-08-02 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating cancer |
| EP2532740A1 (en) | 2011-06-11 | 2012-12-12 | Michael Schmück | Antigen-specific CD4+ and CD8+ central-memory T cell preparations for adoptive T cell therapy |
| CN103483452B (zh) * | 2012-06-12 | 2021-08-13 | 上海细胞治疗集团有限公司 | 双信号独立的嵌合抗原受体及其用途 |
| ES2718903T3 (es) * | 2012-10-24 | 2019-07-05 | Us Health | Receptores de antígenos quiméricos M971 |
| EP3119423B1 (en) * | 2014-03-15 | 2022-12-14 | Novartis AG | Treatment of cancer using chimeric antigen receptor |
| GB201415329D0 (en) * | 2014-07-21 | 2014-10-15 | Ge Healthcare Bio Sciences | Parallel cell processing method and facility |
| JP7372728B2 (ja) * | 2014-10-31 | 2023-11-01 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 改変ｔ細胞に関する方法および組成物 |
| CN106467906B (zh) * | 2015-08-20 | 2019-09-27 | 北京马力喏生物科技有限公司 | 构建体、转基因淋巴细胞及其制备方法和用途 |
| WO2017079703A1 (en) * | 2015-11-05 | 2017-05-11 | Juno Therapeutics, Inc. | Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy |
| EP4212166A1 (en) * | 2015-12-03 | 2023-07-19 | Juno Therapeutics, Inc. | Compositions and methods for reducing immune responses against cell therapies |
| CN109153975A (zh) * | 2015-12-28 | 2019-01-04 | 诺华股份有限公司 | 制备嵌合抗原受体表达细胞的方法 |
| SG10201912624VA (en) * | 2017-04-03 | 2020-02-27 | Kite Pharma Inc | Treatment using chimeric receptor t cells incorporating optimized polyfunctional t cells |
| CN111315403A (zh) * | 2017-09-15 | 2020-06-19 | 凯德药业股份有限公司 | 用于进行具有监管链和身份链生物样品跟踪的患者特异性免疫疗法规程的方法和系统 |
-
2018
- 2018-09-17 CN CN201880060078.9A patent/CN111315403A/zh active Pending
- 2018-09-17 AU AU2018334279A patent/AU2018334279A1/en not_active Abandoned
- 2018-09-17 EP EP22150767.6A patent/EP4035674A1/en active Pending
- 2018-09-17 WO PCT/US2018/051298 patent/WO2019055896A1/en unknown
- 2018-09-17 SG SG11202002327PA patent/SG11202002327PA/en unknown
- 2018-09-17 KR KR1020237011792A patent/KR20230052312A/ko not_active Application Discontinuation
- 2018-09-17 CA CA3075619A patent/CA3075619A1/en active Pending
- 2018-09-17 US US16/646,239 patent/US20200268860A1/en not_active Abandoned
- 2018-09-17 CN CN202210008931.0A patent/CN114533863A/zh active Pending
- 2018-09-17 EP EP18788926.6A patent/EP3681531A1/en not_active Withdrawn
- 2018-09-17 JP JP2020514925A patent/JP2020537635A/ja active Pending
- 2018-09-17 KR KR1020207010509A patent/KR102521245B1/ko active IP Right Grant
-
2020
- 2020-03-11 IL IL273234A patent/IL273234A/en unknown
-
2021
- 2021-11-24 JP JP2021189818A patent/JP2022031770A/ja active Pending
-
2022
- 2022-02-24 US US17/679,521 patent/US20220249631A1/en active Pending
-
2023
- 2023-03-07 AU AU2023201386A patent/AU2023201386A1/en active Pending
- 2023-12-07 JP JP2023207292A patent/JP2024028918A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4035674A1 (en) | 2022-08-03 |
| US20200268860A1 (en) | 2020-08-27 |
| AU2018334279A1 (en) | 2020-04-02 |
| EP3681531A1 (en) | 2020-07-22 |
| CN114533863A (zh) | 2022-05-27 |
| IL273234A (en) | 2020-04-30 |
| JP2024028918A (ja) | 2024-03-05 |
| CN111315403A (zh) | 2020-06-19 |
| JP2022031770A (ja) | 2022-02-22 |
| KR20230052312A (ko) | 2023-04-19 |
| WO2019055896A1 (en) | 2019-03-21 |
| JP2020537635A (ja) | 2020-12-24 |
| KR20200053558A (ko) | 2020-05-18 |
| AU2023201386A1 (en) | 2023-04-13 |
| CA3075619A1 (en) | 2019-03-21 |
| US20220249631A1 (en) | 2022-08-11 |
| KR102521245B1 (ko) | 2023-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273234A (en) | Methods and preparations for performing a patient-specific immunotherapy procedure, with monitoring of the chain of custody and the chain of identity of the biological sample | |
| EP3469499A4 (en) | SYSTEMS AND METHODS FOR AUTOMATED BIOLOGICAL SEQUENCE ANNOTATION AND SCREENING | |
| SG10202103903UA (en) | Systems and methods for assessing biological samples | |
| EP3541284A4 (en) | SYSTEMS AND METHODS FOR SAMPLING WITH REDUCED HEMOLYSIS | |
| HK1249944A1 (zh) | 用於病人和生物樣本識別和跟踪的方法和系統 | |
| EP3430410A4 (en) | SYSTEMS AND METHODS FOR AUTOMATED ANALYSIS | |
| EP3341728A4 (en) | DEVICE AND SYSTEM FOR ANALYZING A SAMPLE, PARTICULARLY BLOOD AND METHODS OF USING SAME | |
| SG10202001197UA (en) | Systems and methods for biological analysis | |
| EP3149464A4 (en) | System and method for electronic biological sample analysis | |
| EP3265785A4 (en) | Methods and systems for performing tissue classification using multi-channel tr-lifs and multivariate analysis | |
| SG11201609825RA (en) | System and method for collection confirmation and sample tracking at the clinical point of use | |
| EP3326054A4 (en) | SYSTEMS AND METHOD FOR ANALYZING HEALTH DATA | |
| EP3207685A4 (en) | Systems and methods for threat analysis of computer data | |
| EP3207499A4 (en) | Methods and systems for classifying biological samples, including optimization of analyses and use of correlation | |
| EP3259067A4 (en) | Devices for biological sample collection and analysis and methods of use thereof | |
| EP3155640A4 (en) | Sample analysis systems and methods of use thereof | |
| SG10201912127QA (en) | Methods and systems for high-throughput blood component collection | |
| EP3209263A4 (en) | Method and apparatus for identifying and tracking biological fluids using rfid | |
| EP3171161A4 (en) | Biological substance quantitative determination method, image processing device, pathological diagnosis support system, and program | |
| EP3221695A4 (en) | Parallel-processing systems and methods for highly scalable analysis of biological sequence data | |
| EP3504553A4 (en) | SYSTEM AND METHOD FOR ANALYZING BIOLOGICAL DATA | |
| EP3254067A4 (en) | Systems and methods for detection and analysis of biological species | |
| EP3200118A4 (en) | Sample traceability device and method for medical research and/or diagnosis | |
| EP3787485A4 (en) | SYSTEMS AND PROCEDURES FOR BLOOD ANALYSIS | |
| EP3257444A4 (en) | Method for data analysis and processing of elasticity detection device, and elasticity detection device |